The prevalence of pulmonary hypertension associated with left heart disease: a systematic review and meta-analysis

医学 肺动脉高压 心脏病学 内科学 前瞻性队列研究 保证 肺心病 入射(几何) 心力衰竭 心脏病 流行病学 梅德林 重症监护医学 血流动力学 呼吸道疾病 光学(聚焦) 右心 试验预测值 心功能测试
作者
Katarina Zeder,Clayton H. Brown,Armella Santi,Lisa Cvirn,Silvia Ulrich,Stephan Rosenkranz,Simon Stewart,Geoff A. Strange,Gabor Kovacs,Bradley A. Maron
出处
期刊:Cardiovascular Research [Oxford University Press]
卷期号:121 (17): 2632-2643 被引量:9
标识
DOI:10.1093/cvr/cvaf226
摘要

AIMS: Pulmonary hypertension (PH) is prognostic and a potentially modifiable cause of adverse outcome across the left heart disease (LHD) spectrum. However, data on the prevalence of PH-LHD analysed systematically using a contemporary diagnostic framework are lacking. METHODS AND RESULTS: We performed a systematic literature search including patients with heart failure with preserved or reduced ejection fraction (HFpEF, HFrEF), mitral regurgitation (MR), or aortic stenosis (AS) in three Western European countries (Austria, Germany, Switzerland; total population ∼102 million in 2024). Studies reporting peak tricuspid regurgitation velocity (TRV) from echocardiography or mean pulmonary arterial pressure (mPAP) from right heart catheterization were included. We used a two-strata system to classify PH-LHD: 'at-risk' (TRV >2.8 m/s) or 'manifest' (TRV >3.4 m/s in combination with mPAP >20 mmHg, to account for RHC referral bias). Meta-analysis was performed using a generalized linear mixed model. From n = 123 reports including 51 333 patients, there were n = 34, n = 17, n = 39, and n = 37 studies focusing on HFpEF, HFrEF, AS, and MR, respectively. PH prevalence estimates based on TRV > 2.8 m/s for patients with established HFpEF, HFrEF, AS, and MR were 62% [95% confidence interval (CI): 49-74%], 66% (95% CI: 57-74%), 73% (95% CI: 68-78%), and 80% (95% CI: 76-83%), respectively, and 20% (95% CI: 7-33%), 34% (95% CI: 24-43%), 38% (95% CI: 31-45%), and 54% (95% CI: 49-59%) when using TRV >3.4 m/s in combination with mPAP >20 mmHg, respectively. Extrapolation resulted in 2287 (95% CI: 1770-2804)/100 000 individuals 'at risk' and 805 (95% CI: 325-1285)/100 000 individuals with 'manifest' PH associated with heart failure (HFpEF and HFrEF combined). In addition, 712 (95% CI: 637-787)/100 000 individuals and 413 (95% CI: 347-480)/100 000 individuals had 'at risk' and 'manifest' PH associated with AS or MR, respectively. These collective data suggest that ∼2.7% of the population have 'at risk' and ∼1.0% 'manifest' PH-LHD in Austria, Germany, and Switzerland in 2024. CONCLUSION: The prevalence of PH in patients with from LHD is considerable, although estimates vary by cardiac subtype and specificity of diagnostic criteria. These data warrant prospective studies emphasizing focus on PH detection and management for people with LHD, particularly heart failure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
予诺发布了新的文献求助10
2秒前
WC241002292完成签到,获得积分10
3秒前
4秒前
酷波er的应助被Tao2023采纳,获得30
6秒前
wxy完成签到,获得积分10
6秒前
忧虑的青旋完成签到,获得积分10
6秒前
小陈发布了新的文献求助10
7秒前
斯文败类的应助被迟安歌采纳,获得10
7秒前
张汉三完成签到 ,获得积分10
8秒前
Yumm完成签到 ,获得积分10
8秒前
wxy发布了新的文献求助10
9秒前
快乐小狗旺旺喵完成签到,获得积分20
12秒前
12秒前
12秒前
小张呢好完成签到,获得积分10
13秒前
科研通AI6.2的应助被action采纳,获得10
16秒前
ding的应助被小陈采纳,获得10
16秒前
执着的尔容完成签到,获得积分10
20秒前
研友_VZG7GZ的应助被863采纳,获得10
21秒前
Bright完成签到 ,获得积分10
22秒前
秋风的应助被DW采纳,获得10
24秒前
Pursue。完成签到,获得积分10
24秒前
26秒前
TPolymer完成签到,获得积分10
29秒前
脑洞疼的应助被扶竹苏春采纳,获得10
30秒前
化学废材完成签到,获得积分10
31秒前
CodeCraft的应助被hyska采纳,获得10
32秒前
含蓄书桃发布了新的文献求助10
33秒前
33秒前
34秒前
35秒前
健康的魔镜完成签到 ,获得积分10
37秒前
华无剑的应助被DW采纳,获得10
37秒前
38秒前
小乐乐完成签到 ,获得积分10
38秒前
斯文败类的应助被淡淡青枫采纳,获得10
40秒前
41秒前
山海不远发布了新的文献求助10
42秒前
uniphoton完成签到,获得积分10
43秒前
fatal发布了新的文献求助10
45秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188339
求助须知:如何正确求助?哪些是违规求助? 9576127
关于积分的说明 21845709
捐赠科研通 7786389
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559588
邀请新用户注册赠送积分活动 2482196